Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$24.59 - $35.83 $133,572 - $194,628
5,432 Added 32.82%
21,984 $782,000
Q3 2023

Nov 13, 2023

SELL
$21.07 - $29.77 $730,855 - $1.03 Million
-34,687 Reduced 67.7%
16,552 $446,000
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $683,015 - $1.31 Million
51,239 New
51,239 $1.2 Million
Q2 2022

Aug 11, 2022

SELL
$8.28 - $13.88 $150,141 - $251,686
-18,133 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$11.18 - $24.02 $202,726 - $435,554
18,133 New
18,133 $203,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.6B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.